인쇄하기
취소

Alvogen & AZ signs sales agreement of 3 antibodies for breast and prostate cancer

Published: 2016-10-13 10:31:20
Updated: 2016-10-13 10:31:20

On the 11th, Alvogen Korea(CEO Young-Hee Jang) announced the Korean exclusive sales agreement of AstraZeneca’s(CEO Liz Chatwin) antibodies, Zoladex(generic name: goserelin), Arimidex(generic name: anastrozole) and Casodex(generic name: bicalutamide). Thus, AstraZeneca Korea will supply the drugs, and Alvogen Korea will start marketing and sales activities in Korea from this October.  

Zoladex ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.